{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:02:59Z","timestamp":1789398179800,"version":"build-2803163510"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T00:00:00Z","timestamp":1783900800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"crossref","award":["JP266k0237001"],"award-info":[{"award-number":["JP266k0237001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs - Real World Outcomes"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s40801-026-00567-5","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T15:11:23Z","timestamp":1783955483000},"page":"395-408","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Treatment Selection Patterns and Associated Outcomes for Biguanides and SGLT2 Inhibitors in Type 2 Diabetes: A Retrospective Database Study in Japan"],"prefix":"10.1007","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-7331-6847","authenticated-orcid":false,"given":"Ryo","family":"Mishima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4238-0334","authenticated-orcid":false,"given":"Daisuke","family":"Koide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"key":"567_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.109119","volume":"183","author":"H Sun","year":"2022","unstructured":"Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et\u00a0al. IDF diabetes atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119. https:\/\/doi.org\/10.1016\/j.diabres.2021.109119.","journal-title":"Diabetes Res Clin Pract"},{"issue":"1084","key":"567_CR2","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1136\/postgradmedj-2015-133281","volume":"92","author":"F Zaccardi","year":"2016","unstructured":"Zaccardi F, Webb DR, Yates T, Davies MJ. Pathophysiology of type 1 and type 2 diabetes mellitus: a 90-year perspective. Postgrad Med J. 2016;92(1084):63\u20139. https:\/\/doi.org\/10.1136\/postgradmedj-2015-133281.","journal-title":"Postgrad Med J"},{"key":"567_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108072","volume":"162","author":"R Williams","year":"2020","unstructured":"Williams R, Karuranga S, Malanda B, Saeedi P, Basit A, Besan\u00e7on S, et\u00a0al. Global and regional estimates and projections of diabetes-related health expenditure: results from the international diabetes federation diabetes atlas. Diabetes Res Clin Pract. 2020;162:108072. https:\/\/doi.org\/10.1016\/j.diabres.2020.108072.","journal-title":"Diabetes Res Clin Pract"},{"key":"567_CR4","unstructured":"Ministry of Health, Labour and Welfare. [Explanatory materials for promoting health japan 21 (third term), in japanese] (kenko nihon 21 (dai-sannji) suishin no tame no setsumei shiryo). 2023. https:\/\/www.mhlw.go.jp\/content\/001426890.pdf. Accessed 4 Sept 2025."},{"issue":"1","key":"567_CR5","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s11892-019-1122-9","volume":"19","author":"T Urakami","year":"2019","unstructured":"Urakami T, Kuwabara R, Yoshida K. Economic impact of diabetes in Japan. Curr Diab Rep. 2019;19(1):2. https:\/\/doi.org\/10.1007\/s11892-019-1122-9.","journal-title":"Curr Diab Rep"},{"issue":"6","key":"567_CR6","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.2337\/dc12-1235","volume":"36","author":"K Kodama","year":"2013","unstructured":"Kodama K, Tojjar D, Yamada S, Toda K, Patel CJ, Butte AJ. Ethnic differences in the relationship between insulin sensitivity and insulin response: a systematic review and meta-analysis. Diabetes Care. 2013;36(6):1789\u201396. https:\/\/doi.org\/10.2337\/dc12-1235.","journal-title":"Diabetes Care"},{"issue":"1","key":"567_CR7","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/nyas.12098","volume":"1281","author":"RC Ma","year":"2013","unstructured":"Ma RC, Chan JC. Type 2 diabetes in east asians: similarities and differences with populations in Europe and the united states. Ann N Y Acad Sci. 2013;1281(1):64\u201391. https:\/\/doi.org\/10.1111\/nyas.12098.","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"567_CR8","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1007\/s13300-018-0431-3","volume":"9","author":"H Murayama","year":"2018","unstructured":"Murayama H, Imai K, Odawara M. Factors influencing the prescribing preferences of physicians for drug-naive patients with type 2 diabetes mellitus in the real-world setting in japan: insight from a web survey. Diabetes Ther. 2018;9(3):1185\u201399. https:\/\/doi.org\/10.1007\/s13300-018-0431-3.","journal-title":"Diabetes Ther"},{"issue":"2","key":"567_CR9","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/jdi.13636","volume":"13","author":"R Bouchi","year":"2022","unstructured":"Bouchi R, Sugiyama T, Goto A, Imai K, Ihana-Sugiyama N, Ohsugi M, et\u00a0al. Retrospective nationwide study on the trends in first-line antidiabetic medication for patients with type 2 diabetes in Japan. Diabetes Res Clin Pract. 2022;13(2):280\u201391. https:\/\/doi.org\/10.1111\/jdi.13636.","journal-title":"Diabetes Res Clin Pract"},{"issue":"5","key":"567_CR10","doi-asserted-by":"publisher","first-page":"327","DOI":"10.4327\/jsnfs.77.327","volume":"77","author":"K Tanabe","year":"2024","unstructured":"Tanabe K. Clinical effects and mechanism of action of metformin, in Japanese (metohorumin no rinshoteki koka to sayoukijo). J Jpn Soc Nutr Food Sci. 2024;77(5):327\u201331. https:\/\/doi.org\/10.4327\/jsnfs.77.327.","journal-title":"J Jpn Soc Nutr Food Sci"},{"key":"567_CR11","unstructured":"The Japan Diabetes Society. Recommendations on the proper use of metformin, in Japanese (metohorumin no tekisei shiyo ni kansuru recommendation). 2020. https:\/\/www.nittokyo.or.jp\/modules\/information\/index.php?content_id=23. Accessed 4 Sept 2025."},{"key":"567_CR12","doi-asserted-by":"publisher","unstructured":"McMurray JJ, Solomon SD, Inzucchi SE, K\u00f8ber L, Kosiborod MN, Martinez FA, Ponikowski P, Sabatine MS, Anand IS, B?lohl\u00e1vek J, et\u00a0al. Dapagliflozin in patients with heart failure and reduced ejection fraction. N Engl J Med. 2019;381(21):1995\u20132008. https:\/\/doi.org\/10.1056\/NEJMoa1911303","DOI":"10.1056\/NEJMoa1911303"},{"key":"567_CR13","doi-asserted-by":"publisher","unstructured":"Committee on the Proper Use of SGLT2 Inhibitors. Recommendations on the proper use of SGLT2 inhibitors. J Diabetes Investig. 2020;11(1):257\u201361. https:\/\/doi.org\/10.1111\/jdi.13160.","DOI":"10.1111\/jdi.13160"},{"issue":"2","key":"567_CR14","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa2204233","volume":"388","author":"EMPA-Kidney Collaborative Group","year":"2023","unstructured":"EMPA-Kidney Collaborative Group. Empagliflozin in patients with chronic kidney disease. N Engl J Med. 2023;388(2):117\u201327. https:\/\/doi.org\/10.1056\/NEJMoa2204233.","journal-title":"N Engl J Med"},{"issue":"1","key":"567_CR15","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1111\/jdi.13960","volume":"14","author":"R Bouchi","year":"2023","unstructured":"Bouchi R, Kondo T, Ohta Y, Goto A, Tanaka D, Satoh H, et\u00a0al. A consensus statement from the Japan diabetes society: a proposed algorithm for pharmacotherapy in people with type 2 diabetes. J Diabetes Investig. 2023;14(1):151\u201364. https:\/\/doi.org\/10.1111\/jdi.13960.","journal-title":"J Diabetes Investig"},{"key":"567_CR16","unstructured":"Life Data Initiative General Incorporated Association. Introduction to millennium medical record secondary use database utilization service, in Japanese (sennen karute nijiriyo database rikatsuyou service no goshokai). 2024. https:\/\/www.ldi.or.jp\/download. Accessed 14 Jan 2024."},{"issue":"1","key":"567_CR17","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1037\/a0024918","volume":"17","author":"G Hong","year":"2012","unstructured":"Hong G. Marginal mean weighting through stratification: a generalized method for evaluating multivalued and multiple treatments with nonexperimental data. Psychol Methods. 2012;17(1):44. https:\/\/doi.org\/10.1037\/a0024918.","journal-title":"Psychol Methods"},{"issue":"8","key":"567_CR18","doi-asserted-by":"publisher","first-page":"326","DOI":"10.2188\/jea.JE20180255","volume":"30","author":"S Ono","year":"2020","unstructured":"Ono S, Ono Y, Koide D, Yasunaga H. Association between routine nephropathy monitoring and subsequent change in estimated glomerular filtration rate in patients with diabetes mellitus: a Japanese non-elderly cohort study. J Epidemiol. 2020;30(8):326\u201331. https:\/\/doi.org\/10.2188\/jea.JE20180255.","journal-title":"J Epidemiol"},{"key":"567_CR19","doi-asserted-by":"publisher","unstructured":"Rubin DB. Multiple imputation for nonresponse in surveys. New York: Wiley; 1987. https:\/\/doi.org\/10.1002\/9780470316696.","DOI":"10.1002\/9780470316696"},{"key":"567_CR20","doi-asserted-by":"publisher","unstructured":"Ho DE, Imai K, King G, Stuart EA. Matching as nonparametric preprocessing for reducing model dependence in parametric causal inference. Polit Anal. 2007;15(3):199\u2013236. https:\/\/doi.org\/10.1093\/pan\/mpl013.","DOI":"10.1093\/pan\/mpl013"},{"issue":"3","key":"567_CR21","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s13340-025-00818-w","volume":"16","author":"Y Seno","year":"2025","unstructured":"Seno Y, Ikeguchi E, Yabe D. Evolving incretin-based therapies in Japan: optimizing treatment strategies for diverse clinical and socioeconomical profiles in type 2 diabetes. Diabetol Int. 2025;16(3):457\u201368. https:\/\/doi.org\/10.1007\/s13340-025-00818-w.","journal-title":"Diabetol Int"},{"issue":"1","key":"567_CR22","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/ajh.2011.179","volume":"25","author":"D Banerjee","year":"2012","unstructured":"Banerjee D, Chung S, Wong EC, Wang EJ, Stafford RS, Palaniappan LP. Underdiagnosis of hypertension using electronic health records. Am J Hypertens. 2012;25(1):97\u2013102. https:\/\/doi.org\/10.1038\/ajh.2011.179.","journal-title":"Am J Hypertens"},{"issue":"3","key":"567_CR23","doi-asserted-by":"publisher","first-page":"e392","DOI":"10.1093\/pubmed\/fdv155","volume":"38","author":"M Peng","year":"2016","unstructured":"Peng M, Chen G, Kaplan GG, Lix LM, Drummond N, Lucyk K, et\u00a0al. Methods of defining hypertension in electronic medical records: validation against national survey data. J Public Health. 2016;38(3):e392\u20139. https:\/\/doi.org\/10.1093\/pubmed\/fdv155.","journal-title":"J Public Health"},{"issue":"8","key":"567_CR24","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1111\/dom.13750","volume":"21","author":"M Koshizaka","year":"2019","unstructured":"Koshizaka M, Ishikawa K, Ishibashi R, Maezawa Y, Sakamoto K, Uchida D, et\u00a0al. Comparing the effects of ipragliflozin versus metformin on visceral fat reduction and metabolic dysfunction in Japanese patients with type 2 diabetes treated with sitagliptin: a prospective, multicentre, open-label, blinded-endpoint, randomized controlled study (PRIME-v study). Diabetes Obes Metab. 2019;21(8):1990\u20135. https:\/\/doi.org\/10.1111\/dom.13750.","journal-title":"Diabetes Obes Metab"},{"issue":"9","key":"567_CR25","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1007\/s13340-024-00723-8","volume":"15","author":"R Bouchi","year":"2024","unstructured":"Bouchi R, Kondo T, Ohta Y, Goto A, Tanaka D, Satoh H, et\u00a0al. A consensus statement from the Japan diabetes society: a proposed algorithm for pharmacotherapy in people with type 2 diabetes-2nd edition (english version). J Diabetes Investig. 2024;15(9):1326\u201342. https:\/\/doi.org\/10.1007\/s13340-024-00723-8.","journal-title":"J Diabetes Investig"},{"issue":"5","key":"567_CR26","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1080\/03007995.2018.1551192","volume":"35","author":"R Nishimura","year":"2019","unstructured":"Nishimura R, Kato H, Kisanuki K, Oh A, Onishi Y, Guelfucci F, et\u00a0al. Comparison of persistence and adherence between fixed-dose combinations and two-pill combinations in Japanese patients with type 2 diabetes. Curr Med Res Opin. 2019;35(5):869\u201378. https:\/\/doi.org\/10.1080\/03007995.2018.1551192.","journal-title":"Curr Med Res Opin"},{"issue":"3","key":"567_CR27","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1111\/jdi.13952","volume":"14","author":"A Kashiwagi","year":"2023","unstructured":"Kashiwagi A, Shoji S, Kosakai Y, Koga T, Asakawa K, Rokuda M. Cardiometabolic risk reductions in patients with type 2 diabetes mellitus newly treated with a sodium-glucose cotransporter 2 inhibitor versus a dipeptidyl peptidase-4 inhibitor: a real-world administrative database study in Japan. J Diabetes Investig. 2023;14(3):404\u201316. https:\/\/doi.org\/10.1111\/jdi.13952.","journal-title":"J Diabetes Investig"},{"key":"567_CR28","unstructured":"The Japan Diabetes Society. [Diabetes treatment guide 2024](tonyobyo shinryo gaidorain 2024). Nankodo; 2024. https:\/\/www.jds.or.jp\/modules\/publication\/index.php?content_id=4. Accessed 25 Mar 2026."},{"key":"567_CR29","unstructured":"Ministry of Health, Labour and Welfare. NDB open data. https:\/\/www.mhlw.go.jp\/stf\/seisakunitsuite\/bunya\/0000177182.html. Accessed 13 Sept 2025."}],"container-title":["Drugs - Real World Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40801-026-00567-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40801-026-00567-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40801-026-00567-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T14:05:28Z","timestamp":1789394728000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40801-026-00567-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,13]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["567"],"URL":"https:\/\/doi.org\/10.1007\/s40801-026-00567-5","relation":{},"ISSN":["2199-1154","2198-9788"],"issn-type":[{"value":"2199-1154","type":"print"},{"value":"2198-9788","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,13]]},"assertion":[{"value":"21 June 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"None declared.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study received approval from the Millennium Medical Record Database Review Committee (2024_MIL_0002) and was registered on the University of Tokyo Clinical Research Ethics Committee (2024296NIe).","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}}]}}